LH – Laboratory Corporation of America Holdings
Labcorp Holdings Inc.LH
$238.56Name : Labcorp Holdings Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $19,952,990,208.00
EPSttm : 5.27
Labcorp Holdings Inc.
$238.56
0.09%$0.21Float Short %
2.3
Margin Of Safety %
22
Put/Call OI Ratio
0.64
EPS Next Q Diff
0.36
EPS Last/This Y
9.72
EPS This/Next Y
1.48
Price
238.87
Target Price
266.44
Analyst Recom
1.76
Performance Q
10.09
Relative Volume
1.14
Beta
1.06
Ticker: LH
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | LH | 226.99 | 0.84 | 0.52 | 4948 |
| 2024-12-20 | LH | 228.66 | 0.83 | 1.03 | 5069 |
| 2024-12-23 | LH | 227.9 | 0.84 | 0.03 | 3170 |
| 2024-12-24 | LH | 229.49 | 0.72 | 0.54 | 3491 |
| 2024-12-26 | LH | 231.1 | 0.72 | 8.00 | 3530 |
| 2024-12-27 | LH | 230.62 | 0.93 | 0.31 | 4056 |
| 2024-12-30 | LH | 228.82 | 0.93 | 0.30 | 4082 |
| 2024-12-31 | LH | 229.29 | 0.93 | 0.31 | 4093 |
| 2025-01-02 | LH | 228.19 | 0.93 | 0.54 | 4097 |
| 2025-01-03 | LH | 229.2 | 0.92 | 0.08 | 4121 |
| 2025-01-06 | LH | 229.97 | 0.90 | 0.12 | 4179 |
| 2025-01-07 | LH | 235.27 | 0.89 | 0.11 | 4209 |
| 2025-01-08 | LH | 234.33 | 0.89 | 0.01 | 4210 |
| 2025-01-09 | LH | 234.31 | 0.89 | 0.01 | 4210 |
| 2025-01-10 | LH | 232 | 0.70 | 0.50 | 4831 |
| 2025-01-13 | LH | 234.44 | 0.71 | 15.11 | 4814 |
| 2025-01-14 | LH | 234.46 | 0.72 | 3.04 | 4873 |
| 2025-01-15 | LH | 237.17 | 0.67 | 0.30 | 4868 |
| 2025-01-16 | LH | 238.67 | 0.67 | 0.24 | 4866 |
| 2025-01-17 | LH | 238.87 | 0.64 | 0.00 | 5375 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | LH | 227.05 | 2.9 | 939.1 | 14.52 |
| 2024-12-20 | LH | 228.45 | 2.9 | 943.4 | 14.52 |
| 2024-12-23 | LH | 227.84 | 2.9 | 930.3 | 14.52 |
| 2024-12-24 | LH | 229.49 | 2.9 | 944.4 | 14.52 |
| 2024-12-26 | LH | 231.06 | 2.9 | 943.9 | 14.52 |
| 2024-12-27 | LH | 230.71 | 2.9 | 932.8 | 14.52 |
| 2024-12-30 | LH | 228.90 | 2.9 | 925.9 | 14.52 |
| 2024-12-31 | LH | 229.07 | 2.9 | 936.0 | 14.52 |
| 2025-01-02 | LH | 228.20 | 2.9 | 928.3 | 14.52 |
| 2025-01-03 | LH | 229.15 | 2.9 | 940.4 | 14.52 |
| 2025-01-06 | LH | 229.90 | 2.9 | 939.1 | 14.52 |
| 2025-01-07 | LH | 235.16 | 2.9 | 965.1 | 14.52 |
| 2025-01-08 | LH | 234.31 | 2.9 | 930.3 | 14.52 |
| 2025-01-09 | LH | 234.31 | 2.9 | 934.8 | 14.52 |
| 2025-01-10 | LH | 232.00 | 2.9 | 921.6 | 14.52 |
| 2025-01-13 | LH | 234.25 | 2.9 | 947.7 | 14.52 |
| 2025-01-14 | LH | 234.54 | 2.9 | 937.3 | 14.52 |
| 2025-01-15 | LH | 237.30 | 2.9 | 950.7 | 14.52 |
| 2025-01-16 | LH | 238.80 | 2.9 | 943.2 | 14.52 |
| 2025-01-17 | LH | 238.87 | 2.8 | 935.3 | 14.52 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | LH | -16.12 | -1.59 | 2.37 |
| 2024-12-20 | LH | -16.12 | -1.59 | 2.37 |
| 2024-12-23 | LH | -16.03 | -1.59 | 2.37 |
| 2024-12-24 | LH | -16.03 | -1.59 | 2.37 |
| 2024-12-26 | LH | -16.03 | -1.59 | 2.36 |
| 2024-12-27 | LH | -16.12 | -1.59 | 2.36 |
| 2024-12-30 | LH | -16.16 | -1.60 | 2.36 |
| 2024-12-31 | LH | -16.16 | -1.60 | 2.36 |
| 2025-01-02 | LH | -16.10 | -1.60 | 2.36 |
| 2025-01-03 | LH | -16.12 | -1.60 | 2.36 |
| 2025-01-06 | LH | -16.07 | -1.64 | 2.36 |
| 2025-01-07 | LH | -16.07 | -1.64 | 2.36 |
| 2025-01-08 | LH | -16.37 | -1.64 | 2.36 |
| 2025-01-09 | LH | -16.37 | -1.64 | 2.36 |
| 2025-01-10 | LH | -16.37 | -1.64 | 2.36 |
| 2025-01-13 | LH | -16.37 | -1.02 | 2.30 |
| 2025-01-14 | LH | -16.37 | -1.02 | 2.30 |
| 2025-01-15 | LH | -16.37 | -1.02 | 2.30 |
| 2025-01-16 | LH | -16.37 | -1.02 | 2.30 |
| 2025-01-17 | LH | -16.37 | -1.02 | 2.30 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
3.5
Avg. EPS Est. Current Quarter
3.4
Avg. EPS Est. Next Quarter
3.86
Insider Transactions
-16.37
Institutional Transactions
-1.02
Beta
1.06
Average Sales Estimate Current Quarter
3309
Average Sales Estimate Next Quarter
3410
Fair Value
290.51
Quality Score
59
Growth Score
77
Sentiment Score
81
Actual DrawDown %
12.3
Max Drawdown 5-Year %
-46.6
Target Price
266.44
P/E
46.19
Forward P/E
14.88
PEG
5.49
P/S
1.57
P/B
2.44
P/Free Cash Flow
23.66
EPS
5.16
Average EPS Est. Cur. Y
14.52
EPS Next Y. (Est.)
16
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
3.43
Relative Volume
1.14
Return on Equity vs Sector %
-13.7
Return on Equity vs Industry %
-5
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
935.3
Labcorp Holdings Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 67000
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.
stock quote shares LH – Laboratory Corporation of America Holdings Stock Price stock today
news today LH – Laboratory Corporation of America Holdings stock forecast ,stock prediction 2023 2024 2025
marketwatch LH – Laboratory Corporation of America Holdings yahoo finance google finance
stock history LH – Laboratory Corporation of America Holdings invest stock market
stock prices LH premarket after hours
ticker LH fair value insiders trading